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Nuclear receptors (NRs) are key regulators of cell function and differentiation. We examined NR expression during osteogenic versus
adipogenic differentiation of primary mouse calvarial osteoblasts (MOBs). MOBs were cultured for 21 days in osteogenic or adipogenic
differentiation media. von Kossa and Oil Red O staining, and qRT-PCR of marker genes and 49 NRs were performed. PCR amplicons were
subcloned to establish correct sequences and absolute standard curves. Forty-three NRs were detected at days 0–21. Uncentered average
linkage hierarchical clustering identified four expression clusters: NRs (1) upregulated during osteogenic, but not adipogenic, differentiation,
(2) upregulated in both conditions, with greater upregulation during adipogenic differentiation, (3) upregulated equally in both conditions,
(4) downregulated during adipogenic, but not osteogenic, differentiation. One-way ANOVA with contrast revealed 20 NRs upregulated during
osteogenic differentiation and 12 NRs upregulated during adipogenic differentiation. Two-way ANOVA demonstrated that 18 NRs were
higher in osteogenic media, while 9 NRs were higher in adipogenic media. The time effect revealed 16 upregulated NRs. The interaction of
condition with time revealed 6 NRs with higher expression rate during adipogenic differentiation and 3 NRs with higher expression rate
during osteogenic differentiation. Relative NR abundance at days 0 and 21 were ranked. Basal ranking changed at least 5 positions for 13 NRs
in osteogenic media and 9 NRs in adipogenic media. Osteogenic and adipogenic differentiation significantly altered NR expression in MOBs.
These differences offer a fingerprint of cellular commitment and may provide clues to the underlying mechanisms of osteogenic versus
adipogenic differentiation. J. Cell. Biochem. 105: 1316–1326, 2008.  2008 Wiley-Liss, Inc.KEY WORDS: OSTEOGENIC; ADIPOGENIC; NUCLEAR RECEPTORS; DIFFERENTIATIONR educed bone formation resulting from osteoporosis, ovar-iectomy, skeletal unloading, glucocorticoid therapy or
normal aging is characterized by significantly decreased osteoblast
number and increased bone marrow adipocyte number [Meunier
et al., 1971; Wang et al., 1977; Burkhardt et al., 1987; Justesen
et al., 2001; Marie and Kaabeche, 2006]. Because adipocytes and
osteoblasts share a common progenitor [Bellows and Heersche,
2001], it is hypothesized that osteoporosis and osteopenia occur
when progenitors preferentially differentiate toward adipocytes1316
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Drug discovery research aimed at shifting this differentiation
balance towards osteoblasts is yielding promising results [see review
by Nuttall and Gimble, 2000].
Calvaria-derived osteoblasts are one of the most widely used
primary osteoblast models. The pool of cells collected from
collagenase-digested 1-week-old mouse calvariae is enriched in
osteoblasts that form mineralized nodules and express lineage-
specific markers when cultured in osteogenic media [Garcia et al.,
2002; Kalajzic et al., 2002]. The overwhelming majority of calvaria-
derived cells (>80%) are committed osteoblasts with a small
population of progenitors that differentiate toward osteoblasts,
adipocytes and chondrocytes [Bellows and Heersche, 2001; Zhang
et al., 2006].
Osteoblasts and adipocytes share a common progenitor whose
fate correlates with the expression of cbfa1/runx2 or PPARg,
respectively [Tontonoz et al., 1995a; Ducy et al., 1997]. Cbfa1/runx2
is a runt homology domain transcription factor that triggers
expression of key osteoblastic genes [Ducy, 2000]. PPARg is a
nuclear receptor (NR) that targets adipogenic genes and plays a
major role in metabolic diseases [Lehrke and Lazar, 2005].
The NR superfamily has 49 members that are subdivided into
seven families based on sequence homology and function
[Robinson-Rechavi et al., 2003]. Among the functions performed
by NRs is regulation of cellular differentiation both prenatally and
postnatally. Indeed, NRs are critical for normal functioning in
several organ systems, which makes them especially attractive drug
targets when disease strikes these systems [see Anon., 2006].
NRs are also important osteoblast regulators, with several steroid
hormone receptors affecting bone growth and bone mineral density
[Gimble et al., 2006]. Due to their importance in cell differentiation
and their role in fat and bone metabolism and the close relationship
between osteoblasts and adipocytes [Gimble et al., 2006], we
investigated the expression patterns of all the known NR family
members in calvarial cell undergoing differentiation into osteo-
blastic or adipogenic phenotypes. NR profiling of adipocytic 3T3-L1
cells, macrophages and mouse tissues highlight the power of this
technique to not only assay differences in NR expression among
tissues but also to provide insights into the molecular regulators that
may contribute to cellular differentiation [Barish et al., 2005; Fu
et al., 2005; Bookout et al., 2006]. We cultured primary mouse
calvarial cells in osteogenic and adipogenic media for 21 days and
assayed mRNA levels for all 49 NRs by real-time PCR (qRT-PCR).
Statistical analyses were then performed on the qRT-PCR data to




Unless otherwise indicated, all reagents were purchased from
Sigma–Aldrich (St. Louis, MO).
CELL CULTURE
Primary mouse calvariae cells (MOBs) from 6- to 8-day-old CD-1
neonatal mice (Charles River laboratories, Inc., Boston, MA)
[Tetradis et al., 2001a] were isolated and plated at a concentration
of 100,000 cells/ml in DMEM with 10% fetal bovine serum (FBS),
100 units/ml penicillin, and 50 mg/ml streptomycin (Mediatech, Inc
Herndon, VA. Upon confluency (day 0), cells were treated with
osteogenic [Kalajzic et al., 2002] or adipogenic [Cheng et al., 2003]
differentiation media. Media was changed twice a week and at least
2 days prior to RNA extraction.JOURNAL OF CELLULAR BIOCHEMISTRYCELL STAINING
Von Kossa stain: MOBs were fixed with 1% formaldehyde, washed in
cacodylate buffer pH 7.4, incubated in saturated lithium carbonate
and subsequently incubated in 5% silver nitrate for 1 h under ultra-
violet light. Cells were rinsed with water, incubated with 5% sodium
thiosulfate, rinsed again with water and air-dried.
Oil Red O stain: MOBs were fixed in 60% isopropanol for 10 min
and then stained with 0.3% Oil Red O in 60% isopropanol for 15 min.
Subsequently, cells were rinsed with 60% isopropanol and air-dried.
REAL-TIME PCR (qRT-PCR)
Total RNA was collected at days 0, 3, 5, 7, 14, and 21 using Trizol
reagent according to the manufacturer’s protocol (Life Technologies,
Inc., Grand Island, NY). To insure removal of genomic DNA, samples
were then DNase-treated using the DNA-Free kit (Ambion Inc.,
Austin, TX). Threemg total RNA were reverse-transcribed with RNA-
dependent polymerase Moloney murine leukemia virus (Promega)
according to manufacturer’s protocol.
qRT-PCR of each gene was performed in triplicate for at least four
independent experiments. One microliter (1 ng) of reverse-
transcribed product was amplified with iQ SYBR Green master
mix (BioRad, Hercules, CA) and gene-specific primers (Supple-
mental Table I) using the iCycler System and iCycler iQ Optical
System software (BioRad). The amplification program was set for
1 cycle of 958C for 3 min followed by 37 cycles of 958C, 30 sec;
58–678C, 20 sec (see Supplemental Table I for annealing temperature
for specific genes); 728C, 30 sec. Relative gene induction was
determined by the 2DDCt method using b-actin as control and was
expressed as log2 fold induction [Livak and Schmittgen, 2001].
Genes that did not reach threshold by cycle 35 were considered to be
not amplified.
To generate real-time PCR standard curves for each NR,
adipogenic markers (lipoprotein lipase (LPL) and CD36 [Gregoire
et al., 1995; Ibrahimi et al., 1996]) and osteogenic markers (alkaline
phosphatase (ALP) and osteocalcin (OCN); [Aubin et al., 1995]) from
bone, brain, liver and kidney was amplified using gene-specific
primers (Supplemental Table I). PCR products were subcloned into a
TA vector (Invitrogen Inc., Carlsbad, CA) and sequenced (Davis
Sequencing, Davis, CA). Plasmid concentrations were determined
and diluted to generate standard curves.
STATISTICAL ANALYSES
Hierarchical clustering was performed using CLUSTER and TREE-
VIEW software [Eisen et al., 1998]. Genes were clustered using
uncentered Average Linkage Clustering.
Two-way ANOVA with interaction model utilized JMP6 software
(SAS Institute Inc., Cary, NC). This model estimates the independent
effects of culture media and time and the interaction effect of culture
media and time on NR gene mRNA levels. More specifically, this
analysis assesses differences in the mean NR expression for
osteogenic versus adipogenic culture media over all time points
(media effect), differences in the mean NR expression for each time
point averaged over both culture media (time effect), and whether
the time effect varies by media (media time effect). Fold induction
was expressed as log2 fold induction. The significance threshold was
set at 0.05.NR PROFILES IN OSTEOGENESIS AND ADIPOGENESIS 1317
To determine gene expression for each NR in osteogenic and
adipogenic media, data for osteogenic and adipogenic induction
were analyzed using one-way ANOVA with contrast. day 0 was
compared to days 7, 14, and 21 using JMP6 software (SAS Institute).
RANKING
NR gene expression level was calculated based on gene-specific
standard curves, normalized to the length of each amplicon and
expressed relative to b-actin. The NRs were then ranked within each
experiment according to their expression abundance by multiplying
their original rank by 100 and dividing by 43 (the number of NRs
that were regulated in the study). A minimum of three experiments
containing at least 40 genes was utilized to generate the average
gene ranking.RESULTS AND DISCUSSION
VERIFICATION OF MOB OSTEOGENIC AND ADIPOGENIC POTENTIAL
MOBs are osteoblastic cells with adipocytic potential [Zhang et al.,
2006]. To confirm this, MOBs cultured in osteogenic or adipogenic
media were assayed for mineralization or adipogenesis at 0, 7, 14,
and 21 days. MOBs cultured in osteogenic, but not adipogenic,
media demonstrated mineralization by Von Kossa staining at 14 and
21 days (Fig. 1A). On the other hand, MOBs cultured in adipogenic,
but not osteogenic, media exhibited positive Oil Red O staining
beginning at day 7 (Fig. 1B), thus confirming the dual phenotypic
differentiation capacity of primary MOBs.
We next determined if the osteogenic and adipogenic phenotypes
correlate to specific osteoblast and adipocyte molecular markers.
mRNA levels for osteoblast (ALP and OCN) and adipocyte (CD36 and
LPL) markers were measured by qRT-PCR following osteogenic and
adipogenic differentiation for 0–21 days. These data were expressed
as log2-fold induction and were analyzed by two-way ANOVA to
detect differences due to culture media, time or culture med-
ia time. ALP mRNA levels were not affected by culture media
(Fig. 1C,G), while OCN mRNA levels increased in osteogenic media
and decreased in adipogenic media (Fig. 1D,G). CD36 and LPL were
upregulated in both culture conditions; however, the level of
induction for each gene was significantly higher in adipogenic
media compared to osteogenic media (Fig. 1E–G).
Like culture media, time also differentially affected mRNA levels
for OCN, CD36 and LPL, but not ALP (Fig. 1). While culture media
and time independently affected only OCN, CD36 and LPL mRNA
levels, the interaction of culture media time showed that all the
markers were significantly regulated. mRNA levels for ALP and OCN
were higher in osteogenic media over the time period studied, while
LPL and CD36 mRNA levels were higher in adipogenic media during
the same time period (Fig. 1).
We demonstrate here a remarkable plasticity of MOBs cultured in
either osteogenic or adipogenic media. Importantly, striking
osteogenic and adipogenic phenotypes paralleled this genotype
plasticity. These results support the conclusion that MOBs can
acquire an adipocyte-like genotype and phenotype. Osteoblast
acquisition of an adipocytic phenotype [Nuttall et al., 1998;
Ahdjoudj et al., 2004], and vice versa [Justesen et al., 2004; Li et al.,1318 NR PROFILES IN OSTEOGENESIS AND ADIPOGENESIS2005], has been reported. This plasticity is the basis for drug
development designed to shift bone marrow cellularity away from
adipocytes toward osteoblasts in osteoporosis patients [Nuttall and
Gimble, 2004; Rosen and Bouxsein, 2006].
NR PROFILING IN MOBs
Having verified the differentiation fate of MOBs cultured in
osteogenic and adipogenic media, we next measured NR gene
expression in MOBs cultured under osteogenic and adipogenic
conditions. We elected to measure NR gene expression using qRT-
PCR rather than microarray analysis [Beck et al., 2001; Balint et al.,
2003; Billiard et al., 2003; de Jong et al., 2004; Schroeder et al.,
2007]. Our interest was in changes in the NR family of transcription
factors, rather than the entire genome. While microarray chips
contain NR family members, NR expression levels or changes in
expression could be below microarray threshold. In fact, this is
the case, as several reports on osteoblast differentiation using
microarray failed to identify all but one NRs undergoing significant
changes in expression [Balint et al., 2003; Billiard et al., 2003; de
Jong et al., 2004; Schroeder et al., 2007]. Also, we were interested in
quantitating expression changes between the NR family members
during osteogenic and adipogenic differentiation. While more labor
intensive, the profiling approach offers a clearer, albeit less global,
picture of gene expression patterns during MOB differentiation.
Since NRs are critical for differentiation in a number of cell types,
including osteoblasts [Gimble et al., 2006], we elected to use the
profiling approach to study the entire NR family in MOBs.
To perform the NR profiling experiment, we used qRT-PCR to
measure NR gene expression at days 0, 3, 5, 7, 14, and 21 in MOBs
cultured under osteogenic and adipogenic conditions (Fig. 2,
Supplemental Figs. 1–5). PXR, CAR1, TLL, FTZ-F1, DAX-1 and PNX
were not detected at any time point in either osteogenic or
adipogenic culture media; thus, they were not included in
subsequent analyses.
FOUR PATTERNS OF NR GENE EXPRESSION WERE DETECTED IN
MOBs CULTURED IN OSTEOGENIC AND ADIPOGENIC MEDIA
Fold induction of the remaining 43 NRs were calculated and
expressed as log2. These data were then subjected to hierarchical
clustering analysis (Fig. 2A). Four main patterns of NR gene
expression were detected. Pattern 1: NRs upregulated during
osteogenic, but not adipogenic, differentiation (Fig. 2B, Supple-
mental Fig. 1). Pattern 2: NRs upregulated in both culture media but
with a higher upregulation during adipogenic versus osteogenic
differentiation (Fig. 2C, Supplemental Fig. 2). Pattern 3: NRs
upregulated during both adipogenic and osteogenic differentiation
(Fig. 2D, Supplemental Fig. 3). Pattern 4: NRs downregulated during
adipogenic differentiation, but not during osteogenic, differentia-
tion (Fig. 2E, Supplemental Fig. 4). Five NRs (VDR, HNF4a, FXRb,
COUP-TFI and ERRb) did not fall into any of the four patterns
(Fig. 2A, Supplemental Fig. 5).
PATTERN 1: NRs UPREGULATED DURING OSTEOGENIC, BUT NOT
ADIPOGENIC, DIFFERENTIATION
Twenty NRs were significantly upregulated throughout osteogenic
differentiation (Table I). Noteworthy is the increased expression ofJOURNAL OF CELLULAR BIOCHEMISTRY
Fig. 1. Osteogenic and adipogenic differentiation. A: von Kossa stain of MOBs maintained under osteogenic or adipogenic conditions for 0, 7, 14, and 21 days. B: Oil Red
O stain of MOBs maintained under osteogenic or adipogenic conditions for 0, 7, 14, and 21 days. mRNA levels for: (C) ALP, (D) OCN, (E) LPL, (F) CD36 as determined by qRT-PCR
of MOBs maintained under osteogenic or adipogenic conditions for days 0, 3, 5, 14, and 21 days. Graphs of mean SEM normalized to b-actin expressed as log2 fold induction.
G: Effects of culture media, time and media time in the two-way ANOVA with interaction. (þ) Significantly higher in adipogenic culture media. (–) Significantly higher in
osteogenic culture media. All significant time effects showed increased gene expression over time. P< 0.05, P< 0.01, P< 0.001.
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Fig. 2. Cluster analysis of NR expression during osteogenic or adipogenic differentiation. A: Log2 fold induction ratios of gene expression relative to day 0 were used for
hierarchical cluster analysis. Red represents expression levels greater than those on day 0; green represents expression levels less than those on day 0; black represents expression
levels equal to those on day 0. Intensity reflects magnitude of expression. Each column is the average of at least four individual experiments. Clustering identified four main
expression patterns across time and condition. B–E: Plot of mean SEM of NRs in the group expressed as log2 fold induction for days, 0, 3, 5, 7, 14, and 21. B: NRs upregulated
during osteogenic, but not during adipogenic, differentiation. C: NRs upregulated in both conditions but with a higher induction in adipogenic differentiation. D: NRs
upregulated in both conditions. E: NRs downregulated during adipogenic differentiation, but not during osteogenic, differentiation. HNF4a, COUP-TF-I, FXRb, ERRb and VDR
were excluded from the graphs as they did not fall into one of the four primary clusters.all four members of the NR3C family (GR, MR, PR, AR) and the
modest, but significant, increased expression of PPARg, PPARa and
LXRa. No NRs were downregulated during osteogenic differentia-
tion.
Testosterone activates AR to produce significant anabolic effects
in bone at the expense of adipose tissue [Yeh et al., 2002; Singh
et al., 2003; Notini et al., 2007]. Thus, our data are consistent
with published findings for AR’s anabolicity (Fig. 2; Tables I and II).
However, our data contradict data showing that AR expression
increases during adipogenic differentiation of 3T3-L1 cells [Fu et al.,
2005]. This may reflect a difference in lineage commitment between
calvarial bone cells and preadipocytic 3T3-L1 cells.
Although PR was significantly induced in osteogenic media, it
was among the least abundant NRs basally, and culturing for
21 days in osteogenic media did little to change its relative1320 NR PROFILES IN OSTEOGENESIS AND ADIPOGENESISabundance (Fig. 2; Tables I–III). Thus, it should not be surprising that
PR null mice do not exhibit a skeletal phenotype [Ishida et al., 1996;
Pei et al., 2003; Pei et al., 2006]. FXRa is best known for its role in
controlling serum bile acid, cholesterol and triglyceride levels, but it
is also implicated in adipocyte differentiation and intracellular lipid
utilization to counterbalance LXRa activity [Sinal et al., 2000;
Cariou et al., 2006; Kalaany and Mangelsdorf, 2006; Rizzo et al.,
2006]. This is consistent with our finding that FXRa expression was
induced in osteogenic media while LXRa was most strongly induced
by adipogenic media (Fig. 2, Table I).
MR is expressed in osteoblasts and adipocytes [Beavan et al.,
2001; Caprio et al., 2007]. Interestingly, MR levels increase
biphasically in 3T3-L1 cells during adipogenic differentiation,
with peak expression within 1 h of differentiation and a second peak
9–10 days later [Fu et al., 2005]. Thus, our finding that MR was theJOURNAL OF CELLULAR BIOCHEMISTRY
TABLE I. One-Way ANOVA With Contrast of NR Gene Expression




receptor Osteogenic Media Adipogenic Media





NR1C1 PPARa 4.2 14.0
NR1C2 PPARd 2.3
NR1C3 PPARg 4.6 37.0












NR2B1 RXRa 3.2 2.8
NR2B2 RXRb





NR2F6 COUP-TFIII 2.2 2.1
NR3A1 ERa 4.4
NR3A2 ERb













NR gene expression during days 7, 14, and 21 was compared to day 0 utilizing
one-way ANOVA with contrast. Values are fold change values comparing days 7–












NR1B2 RARb  
NR1B3 RARg
NR1C1 PPARa þ 
NR1C2 PPARd þ þ





NR1F3 RORg þ  þ
NR1H2 LXRb þ
NR1H3 LXRa þ  þ


















NR3C1 GR  
NR3C2 MR  
NR3C3 PR   







Culture media, time and media time effects in two-way ANOVA models.
Significantly higher in adipogenic media (þ) or osteogenic media (). All
significant time effects were increasing (overall level for condition effects, rate
of increase or interaction effects).
P< 0.05.
P< 0.01.
P< 0.001.most strongly induced NR in osteogenic media, but was not
significantly induced in adipogenic media (Table I), was unexpected.PATTERN 2: NRs UPREGULATED IN BOTH CULTURE MEDIA BUT
WITH A HIGHER UPREGULATION DURING ADIPOGENIC VERSUS
OSTEOGENIC DIFFERENTIATION
The NRs that showed the highest fold-induction were among the
group expressed more in adipogenic media than osteogenic media.
LXRa, PPARg and RXRg were induced over 37-fold, while PPARa
and Rev-erba were induced 14- and 4.5-fold, respectively, in
adipogenic media (Table I). With the exception of PPARa, these
genes are markedly regulated during 3T3-L1 adipogenic differ-
entiation, with LXRa, RXRg and PPARg expression rising late in
differentiation and Rev-erba having both early and late expressionJOURNAL OF CELLULAR BIOCHEMISTRYpeaks [Fu et al., 2005]. The strong induction of these classic
adipogenic genes in MOBs cultured in adipogenic media supports
the genotypic plasticity of osteoblasts.
LXRa regulates cholesterol homoeostasis, bile acid metabolism,
lipid metabolism and adipocytic differentiation [Tontonoz et al.,
1995b; Juvet et al., 2003; Ulven et al., 2005; Cummins and
Mangelsdorf, 2006]. LXRa and its isoform LXRb are both expressed
in bone, although LXRb is the more strongly expressed of the two,
which we confirm here [Robertson et al., 2006] (Table III).
Surprisingly, given their relative expression levels in bone, it is
LXRa/, rather than LXRb/, mice that have a bone phenotype
[Robertson et al., 2006]. LXRa null females have increased cortical
bone suggesting that LXRa may inhibit bone formation. These data
may also suggest that LXRa preferentially promotes adipocyto-
genesis over osteoblastogenesis. Indeed, our data that LXRa isNR PROFILES IN OSTEOGENESIS AND ADIPOGENESIS 1321









NR2C1 TR2 1 5 1
NR2F6 COUP-TFIII 2 4 4
NR2F2 COUP-TFII 3 6 6
NR2B1 RXRa 4 3 7
NR2F1 COUP-TFI 5 7 8
NR1B3 RARg 6 12 2
NR1I1 VDR 7 8 18
NR4A1 Nur77 8 19 14
NR1A1 TRa 9 11 3
NR1H2 LXRb 10 10 9
NR1C3 PPARg 11 1 5
NR1D1 Rev-erba 12 9 13
NR2B2 RXRb 13 16 10
NR1C2 PPARd 14 15 12
NR3B1 ERRa 15 13 19
NR2C2 TR4 16 17 21
NR1D2 Rev-erbb 17 20 11
NR3C1 GR 18 14 17
NR1H3 LXRa 19 2 16
NR1B1 RARa 20 22 15
NR4A2 Nurr1 21 26 23
NR0B2 SHP 22 24 30
NR1F1 RORa 23 21 22
NR1C1 PPARa 24 18 20
NR3C4 AR 25 23 25
NR5A2 LRH1 26 27 24
NR6A1 GCNF1 27 28 26
NR3A2 ERb 28 31 27
NR2A1 HNF4a 29 32 36
NR1A2 TRb 30 29 29
NR4A3 NOR-1 31 36 31
NR1F2 RORb 32 33 34
NR1F3 RORg 33 25 40
NR3A1 ERa 34 37 32
NR3B2 ERRb 35 30 42
NR3C2 MR 36 34 35
NR1B2 RARb 37 38 37
NR1H4 FXRa 38 39 33
NR2B3 RXRg 39 35 28
NR3C3 PR 40 40 38
NR3B3 ERRg 41 41 39
NR1H5 FXRb 42 42 43
NR2A2 HNF4g 43 43 41
Relative expression levels for each NR were determined at days 0 and 21 of
osteogenic or adipogenic culture.upregulated in MOBs cultured in adipogenic, but not osteogenic,
media supports a role for LXRa in directing the adipogenic
phenotype.
Our finding that PPARg is upregulated in MOBs cultured in
adipogenic media confirms previous findings [Diascro et al., 1998;
Maurin et al., 2005]. There is evidence that the high PPARg levels
that we detected are a major contributor to the adipocytic phenotype
that MOBs acquire in adipogenic media [Kim et al., 2005]. In fact,
PPARg’s potency as an adipogenic factor is so strong that an
adipogenic phenotype results in several cell types in which PPARg is
activated [for recent examples see Hazra et al., 2004; Semple et al.,
2006; Singh et al., 2006; Yamanouchi et al., 2007].
Given the breadth of cell types responsive to PPARg activation,
including osteoblasts [Li et al., 2006], it is likely that osteoporosis
treatments designed to inactivate PPARg would lack specificity,
resulting in potential unwanted side effects. Moreover, confirming
previous observations [Diascro et al., 1998; Nuttall et al., 1998;
Lecka-Czernik et al., 1999], the PPARg activators troglitazone and
ciglitazone demonstrate dose-dependent affects in osteoblastic
MC3T3-E1 cells [Jackson, 1991]. At high doses, both PPARg1322 NR PROFILES IN OSTEOGENESIS AND ADIPOGENESISactivators inhibited mineralization and alkaline phosphatase
activity. However, at low doses (<2.5 mM), troglitazone and
ciglitazone significantly increased mineralization and alkaline
phosphatase activity. Taken together with our data that osteogenic
media increased PPARg expression in osteoblasts, these data suggest
that low-level PPARg activation may enhance osteoblastic activity.
RXRg is highly expressed in muscle, anterior pituitary and brain,
yet RXRg deletion does not affect development, probably due to
redundancy among the RXRa, b and g isoforms [Krezel et al., 1996].
Supporting this is the finding that RXRg mRNA levels increase in
adipocytes in which RXRa is conditionally knocked-out [Metzger
et al., 2005]. Importantly, RXR isoform redundancy appears to have
functional specificity [Metzger et al., 2005]. RXRa deletion in
mature adipocytes blocks excess lipid accumulation and RXRa
deletion in RXRg null adipocytes leads to cell death. Interestingly,
PPARg deletion in mature adipocytes also leads to apoptosis,
suggesting that PPARg-mediated adipocyte survival requires either
RXRa or RXRg and that PPARg-mediated lipid accumulation
requires RXRa. If this were the case, then we would conclude that
increased RXRg in MOBs cultured in adipogenic media might not
contribute to lipid accumulation (Fig. 1), but instead may contribute
to cell survival.
PPARa potently regulates fatty acid oxidation (FAO) genes [Lee
et al., 1995; Schoonjans et al., 1996]. Interestingly, adult female
PPARa null mice develop significant cortical bone porosity [Wu
et al., 2000] and high-dose PPARa activators increase in vitro
osteogenesis [Jackson and Demer, 2000]. Taken together, these data
suggest that PPARa may regulate adipogenesis and osteogenesis by
regulating cellular metabolism. Our finding that both osteogenic
and adipogenic media induced PPARa expression, albeit at different
magnitudes, suggests that PPARa induction in MOBs may allow
these cells to adapt metabolically to varying signals.
Rev-erba is an orphan nuclear receptor that is induced during
adipocyte differentiation [Chawla and Lazar, 1993]. In MOBs, Rev-
erba was induced 4.5-fold in adipogenic media and showed a
significant, but lower, induction in osteogenic media (Fig. 2; Table I).
It is interesting to consider that Rev-erba and Rev-erbb are
transcribed from the antisense strand of the TRa gene and Rev-erba
expression inhibits TRa expression [Munroe and Lazar, 1991;
Chomez et al., 2000]. Consistent with this, we found a reciprocal
relationship between Rev-erba and TRa expression in MOBs
cultured in osteogenic and adipogenic media. While both genes
have relatively high expression (TRa is ranked 9th and Rev-erba is
12th; Table III), adipogenic media increased Rev-erba’s ranking to
9th place, while TRa dropped to 11th. On the other hand, osteogenic
media increased TRa’s position to 3rd and dropped Rev-erba to 13th
place. These data suggest that preferential transcription from this
locus toward TRawill promote osteoblast differentiation, while Rev-
erba expression will promote adipocyte differentiation.
PATTERN 3: NRs UPREGULATED DURING BOTH ADIPOGENIC
AND OSTEOGENIC DIFFERENTIATION
Among the genes equally upregulated in osteogenic and adipogenic
media were COUP-TFIII, RXRa and TRa. Interestingly, RXRa and
TRa are intermediate markers of adipogenic differentiation, having
high basal expression that increases and plateaus 1–2 days afterJOURNAL OF CELLULAR BIOCHEMISTRY
differentiation is initiated [Fu et al., 2005]. We also found high basal
expression for these genes, as well as for COUP-TFIII. In fact, COUP-
TFIII, RXRa and TRa were, respectively, the 2nd, 4th, and 9th most
highly expressed NRs at baseline (Table III).
PATTERN 4: NRs DOWNREGULATED DURING ADIPOGENIC
DIFFERENTIATION, BUT NOT DURING OSTEOGENIC,
DIFFERENTIATION
Nurr1, NOR-1 and ERRg were significantly downregulated in
adipogenic media (Tables I and II). The appearance of Nurr1 and
NOR-1 in this cluster was of particular interest to us, as we showed
that parathyroid hormone (PTH) rapidly and transiently induces
these genes in osteoblasts, thereby classifying them as primary
response genes [Tetradis et al., 2001a,b; Pirih et al., 2003; Pirih et al.,
2005]. Moreover, Nurr1 induces both osteopontin and osteocalcin,
which are important osteoblast differentiation markers [Lammi
et al., 2004; Pirih et al., 2004]. Consistent with their classification as
primary response genes, Nur77, Nurr1 and NOR-1 are also rapidly
and transiently induced following addition of adipogenic differ-
entiation agents in 3T3-L1 cells [Fu et al., 2005]. ERRg expression in
osteoblasts has not been shown previously and its role in adipocyte
function is primarily as an ERRa inducer [Liu et al., 2005].NR EXPRESSION DURING OSTEOGENIC AND ADIPOGENIC
DIFFERENTIATION
NR expression levels plateaued on days 7–21. To avoid spurious
results based on statistical fluctuations and to increase the power of
our statistical methods, we grouped gene expression levels from
days 7, 14, and 21 and performed one-way ANOVA with contrast
between day 0 and the grouped data from days 7 to 21 for osteogenic
and adipogenic culture conditions (Table I).
Twenty NRs were significantly upregulated throughout osteo-
genic differentiation. Noteworthy is the increased expression of all
four members of the NR3C family (GR, MR, PR, AR) and the modest,
but significant, increased expression of PPARg, PPARa and LXRa.
No NRs were downregulated during osteogenic differentiation.
On the other hand, 12 NRs were upregulated during adipogenic
differentiation. These included PPARg, LXRa and RXRg. Moreover,
three NRs (ERRg, Nurr1, NOR-1) were downregulated during
adipogenic differentiation.NR EXPRESSION AS A FUNCTION OF OSTEOGENIC AND
ADIPOGENIC CULTURE MEDIA AND TIME
Having demonstrated that NR gene expression varies in MOBs
cultured in either osteogenic or adipogenic culture media, we next
investigated in greater detail the effect of culture media, time and
the interaction of culture media with time (media time) on NR
expression in MOBs by performing a two-way ANOVA with
interaction analysis on our qRT-PCR data. Twenty-seven NRs were
differentially expressed in osteogenic versus adipogenic culture
media (Table II). Eighteen of these 27 NRs were significantly higher
in osteogenic media, including, the NR3C and NR4A (Nur77, Nurr1,
NOR-1) families and LRH1. The remaining nine NRs were higher in
adipogenic media, including the NR1C (PPARa, b, g) and NR1HJOURNAL OF CELLULAR BIOCHEMISTRY(LXRa, LXRb, FXRa, FXRb) families. Interestingly two members of
the NR1F family (RORb, RORg) were higher in adipogenic media
while one (RORa) was higher in osteogenic media.
When the time effect was analyzed, 16 NRs were upregulated,
while none were downregulated. Among these genes were all four
members of the NR3C family and ERa, ERb, PPARg. The interaction
of culture media with time (media time) revealed that nine NRs
were significantly different. Six had higher expression in adipogenic
media and three NRs had higher expression in osteogenic media over
the time course (Table II).
RANKING OF NR GENE EXPRESSION
Fig. 2 and Tables I and II demonstrated changes in individual NR
levels in MOBs undergoing osteogenic versus adipogenic differ-
entiation. To compare gene expression among NRs, we established
the relative abundance of all NRs at culture day 0 and day 21
(Table III).
At day 21 of osteogenic differentiation, RXRg, TRa, PPARg,
RARa and FXR ranked at least five positions higher, while VDR,
SHP, ERRb, RORg, HNF4a, Nur77 and TR4 ranked at least five
positions lower, relative to their rankings on day 0. TR2 and RARg
were the most highly expressed NRs in MOBs following 21 days in
osteogenic culture media.
LXRa, PPARg, RORg, PPARa, and ERRb ranked at least five
positions higher following adipogenic differentiation. Nur77, RARg,
NOR-1, and Nurr1 ranked at least five positions lower relative to the
ranking of day 0. PPARg and LXRa were the most highly expressed
NRs in MOBs after 21 days of culture in adipogenic media.
CONCLUSIONS
We have demonstrated that MOBs cultured in osteogenic and
adipogenic media acquired distinct phenotypes that correlated with
distinct NR genotypes. Our data provide an initial fingerprint of NR
gene expression in relation to osteoblastic differentiation. Addi-
tional investigation on NR protein expression, specific isoform
regulation and functional analyses, should further provide evidence
of NR involvement in cellular commitment and may offer clues to
the underlying mechanisms of osteoblast differentiation and
function. The remarkable plasticity of the osteoblast genome may
also contribute to the consistent finding that marrow adiposity
increases in patients with bone metabolic diseases such as
osteoporosis. The possibility that selected NRs may be therapeutic
targets to prevent and reverse the debilitating effects of bone loss
warrants consideration. Indeed, NR-targeted therapies are being
designed to treat osteosarcomas [Haydon et al., 2002; Lucarelli et al.,
2002], highlighting the importance of this transcription factor
superfamily in maintaining normal osteoblast function and the
feasibility of designing efficacious drugs to alter NR function.ACKNOWLEDGMENTS
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